Aviva’s Probitas buy to bolster non-life margins through 2024
Shares in London-listed Aviva were muted in early trading on Monday despite positive analysts commentary after the UK insurer surprised the market with news it would once again build a presence in Lloyd’s through the £242mn acquisition of Probitas.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below